Analysis of electronic structures of physostigmine analogs

Acta Pharmacologica Sinica

Volumn 19, Issue 4, 1998, Pages 322-326

  Hu, Zeng Jian ^a   Jiang, Hua Liang ^a   Chen, Jian Zhong ^a   Chen, Kai Xian ^a   Ji, Ru Yun ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Cholinesterase inhibitors; Computer aided design; Molecular models; Physostigmine

Indexed keywords

CHOLINESTERASE INHIBITOR; DIHYDROINDOLINE INHIBITOR; PHYSOSTIGMINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHOLINESTERASE INHIBITION; DRUG MECHANISM; ELECTRONICS; PREDICTION; QUANTUM MECHANICS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

CHOLINESTERASE INHIBITORS; COMPUTER-AIDED DESIGN; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PHYSOSTIGMINE;

EID: 2642673607     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Wang ML, Ji QE. Synthesis of dihydroindoline compounds and their anticholinesterase activity. Acta Pharm Sin 1991; 26: 103-10.
2. Chen BH, Ji QE. Synthesis of indolinyl-N, N-dimethyl carbamates as reversible anticholinesterase agents. Acta Pharm Sin 1990; 25: 247-52.
3. Wang ML, Fu XF, Dai YJ, Xu R. Studies on relationship between the structure of physostigmine analogs and their anticholinesterase activities. Chin J Med Chem 1997; 7: 59-62.
4. SYBYL [computer program]. Version 6.2. St Louis (MO): Tripos Associate Inc, 1995.
5. Cramer RD III, Paterson DE, Bunce JD. Comparative molecular field analysis (CoMFA). I. effect of shape on binding of steroids to carried proteins. J Am Chem Soc 1988; 110: 5959-67.
6. Dewar MJS, Zoebisch EG, Healy EF, Stewart JJP. AM1: A new general purpose quantum mechanical molecular model. J Am Chem Soc 1985; 107: 3902-9.
7. Fukui K. Theory of orientation and stereoselection. New York: Springer-Verlag; 1975. p 34-9.
8. Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toler L, et al. Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science 1991; 253: 872-9.